Navigating evolving regulatory CMC guidance in the AAV gene therapy field
M Brewer, A Cockroft, C Fuentes et al
Driving the expansion of mRNA into the therapeutic sphere
Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu
Regulatory requirements and product attributes for cGMP viral vector production
Scott Cross, Shikha Mishra
Manufacturing considerations underpinning viral & non-viral platform selection
A Hagerman, A Noyes, V Slepushkin et al
Successful suspension-based viral vector manufacturing scale-up from process development to clinic
D Kole, T P Cripe, L Giannunzio et al
The digital revolution: technological innovations to enable automation in cell therapy manufacturing
Bruce Greenwald, Sean Chang, Krish Roy
Current technological trends & advancements in vector purification
Y Cai, N Clement, C Gaskin et al